Overview
American Board of Psychiatry and Neurology
Neurology (#61445), 09/24/2018
American Board of Electrodiagnostic Medicine
Electrodiagnostic Medicine (#4137), 2020
Neuromuscular Ultrasound Certificate of Added Qualification (#84), 2023
American Board of Psychiatry and Neurology
Neuromuscular Disorders (# 914), 10/19/2020UCB Pharmaceuticals/Duke/UNC Neurology Clinical Drug 07/2019 - 09/2021
Raleigh, NC/Durham, NC Development FellowshipCurrent Appointments & Affiliations
Assistant Professor of Neurology
·
2021 - Present
Neurology, Neuromuscular Disease,
Neurology
Recent Publications
Clinical Reasoning: A 60-Year-Old Woman With Rapidly Progressive Muscle Weakness and Ophthalmoparesis.
Journal Article Neurology · August 13, 2024 The clinical assessment of patients with proximal muscle weakness represents a frequent yet intricate challenge. We present the case of a 60-year-old woman who experienced a progressive, symmetrical weakness in proximal limbs and bulbar muscles over 6 mont ... Full text Link to item CiteSafety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study.
Journal Article Lancet Neurol · May 2023 BACKGROUND: Generalised myasthenia gravis is a chronic, unpredictable, and debilitating rare disease, often accompanied by high treatment burden and with an unmet need for more efficacious and well tolerated treatments. Zilucoplan is a subcutaneous, self-a ... Full text Link to item CiteA Case of Probable Multifocal Motor Neuropathy With Clinical Stability for Ten Years After a Single Treatment of Rituximab.
Journal Article J Clin Neuromuscul Dis · March 1, 2022 Multifocal motor neuropathy is a rare, immune-mediated motor neuropathy with asymmetric, often debilitating progressive weakness. The efficacy of intravenous immunoglobulin in this disease is well established; however, the response typically wanes over tim ... Full text Link to item CiteRecent Grants
A Phase 3 Randomized, Double-Blind, Placebo[1]Controlled, Global Study to Evaluate the Efficacy and Safety of Intravenous AOC 1001 for the Treatment of Myotonic Dystrophy Type 1
Clinical TrialPrincipal Investigator · Awarded by Avidity Biosciences · 2024 - 2027Nerve Ultrasound for Diagnosis and Prognosis of GBS
ResearchPrincipal Investigator · Awarded by GBS/CIDP Foundation International · 2020 - 2023A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF CROVALIMAB IN PATIENTS WITH GUILLAIN-BARRÉ SYND
Clinical TrialPrincipal Investigator · Awarded by Genetech · 2022 - 2023View All Grants
Education, Training & Certifications
Penn State Milton S. Hershey Medical Center ·
2014
M.D.